ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Endo International PLC

Endo International PLC (ENDP)

0.2926
0.00
( 0.00% )
更新日時: 09:00:00

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
0.2926
買値
0.29
売値
0.294
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
時価総額
前日終値
0.2926
始値
-
時刻
最終取引時間
-
財務取引量
-
VWAP
-
平均取引量 (3 か月)
-
発行済株式数
235,220,000
配当利回り
-
PER
-0.03
1 株当たり利益 (EPS)
-10.42
歳入
2.01B
純利益
-2.45B

Endo International PLC について

Endo International PLC is a specialty pharmaceutical company with a considerable presence in pain management, urology, orthopedics, endocrinology, bariatrics, and others. It operates in four segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceut... Endo International PLC is a specialty pharmaceutical company with a considerable presence in pain management, urology, orthopedics, endocrinology, bariatrics, and others. It operates in four segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. Some of its products include XIAFLEX, SUPPRELIN, PERCOCET, TESTOPEL, VASOSTRICT, ADRENALIN, and APLISOL. The majority of its revenue comes from the United States. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Dublin, Irl
設立
-

ENDP 最新ニュース

Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting

Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting PR Newswire DUBLIN, Sept. 21, 2023 DUBLIN, Sept. 21, 2023 /PRNewswire/ -- Endo International plc (OTC:...

ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS

ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS PR Newswire DUBLIN, Aug. 8, 2023 DUBLIN, Aug. 8, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) today reported financial results for...

Endo Launches Bivalirudin Injection in Ready-to-Use Vials

Endo Launches Bivalirudin Injection in Ready-to-Use Vials PR Newswire DUBLIN, July 18, 2023 Only ready-to-use liquid format of bivalirudin on the marketDoes not require reconstitution, dilution...

Endo Presents New Data at the American Podiatric Medical Association Annual Meeting

Endo Presents New Data at the American Podiatric Medical Association Annual Meeting PR Newswire DUBLIN, July 13, 2023 DUBLIN, July 13, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ...

Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe

Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe PR Newswire DUBLIN, June...

ENDO REPORTS FIRST-QUARTER 2023 FINANCIAL RESULTS

ENDO REPORTS FIRST-QUARTER 2023 FINANCIAL RESULTS PR Newswire DUBLIN, May 8, 2023 DUBLIN, May 8, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) today reported financial results for the...

Endo Announces Launch of Argatroban Injection Through Premier's ProRx® Private-Label Program

Endo Announces Launch of Argatroban Injection Through Premier's ProRx® Private-Label Program PR Newswire DUBLIN, April 17, 2023 DUBLIN, April 17, 2023 /PRNewswire/ -- Endo International plc (OTC:...

Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Oral Suspension

Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Oral Suspension PR Newswire DUBLIN, April 3, 2023 DUBLIN, April 3, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ...

Endo Provides Top-Line Results from Phase 2 Study of Collagenase Clostridium Histolyticum (CCH) in Participants With Plantar Fibromatosis

Endo Provides Top-Line Results from Phase 2 Study of Collagenase Clostridium Histolyticum (CCH) in Participants With Plantar Fibromatosis PR Newswire DUBLIN, March 13, 2023 DUBLIN, March 13, 2023...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
VCIGVCI Global Ltd
US$ 4.48
(150.28%)
244.6M
WAITop KingWin Ltd
US$ 0.459899
(91.62%)
117.92M
IDAIT Stamp Inc
US$ 0.6631
(81.67%)
284.13M
HWHHWH International Inc
US$ 0.8893
(57.40%)
30.05M
CYCNCyclerion Therapeutics Inc
US$ 2.0694
(52.16%)
27.8M
PGHLPrimega Group Holdings Ltd
US$ 2.14
(-98.01%)
18.59M
OTLKOutlook Therapeutics Inc
US$ 1.7674
(-63.86%)
60.37M
KDLYKindly MD Inc
US$ 1.08
(-42.86%)
3.13M
IMGCIMG Inc
US$ 0.9667
(-39.58%)
4.61M
SYMSymbotic Inc
US$ 23.0301
(-38.44%)
18.79M
IDAIT Stamp Inc
US$ 0.6695
(83.42%)
284.13M
VCIGVCI Global Ltd
US$ 4.4864
(150.64%)
244.6M
NVDANVIDIA Corporation
US$ 134.93
(-1.45%)
169.79M
WAITop KingWin Ltd
US$ 0.4584
(91.00%)
117.93M
MARAMARA Holdings Inc
US$ 26.90
(7.73%)
76.43M

最近閲覧した銘柄

Delayed Upgrade Clock